Try it
Microbiology · Virology: chronic hepatitis E in transplant recipients
Sample itemA kidney transplant recipient on tacrolimus has had raised transaminases for eight months. HEV RNA is repeatedly detected in serum, and hepatitis B and C tests are negative. What is the best initial management?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Reduce immunosuppression, then consider ribavirin
Hepatitis E virus can become chronic in solid organ transplant recipients, with progression to cirrhosis. The first step is to reduce immunosuppression if possible, and persistent viraemia is treated with a course of ribavirin.
Option by option
A. Start entecavir for 48 weeks
Entecavir is a hepatitis B polymerase inhibitor and has no role in HEV infection.
B. Start high-dose oral acyclovir
Acyclovir acts on herpesviruses, not on the RNA virus HEV.
C. Reduce immunosuppression, then consider ribavirin (correct)
Correct. Lowering immunosuppression allows clearance, and ribavirin is used if viraemia persists.
D. Give hepatitis E vaccine alone and observe
Vaccination does not clear established chronic infection.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Microbiology questions
- BacteriologyA patient has profuse painless watery 'rice-water' stools and rapid dehydration. The cau…
- Culture mediaThayer–Martin medium is used selectively to isolate which organism?
- Immunology and serologyWhich of the following is a non-treponemal test for syphilis?
- BacteriologyAlbert's stain is used to demonstrate which of the following?